Task: Answer the MCQ question.
Question: Which drug exhibits a -21.198% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: COc1ccc(NC(=O)COC(=O)C2CCN(S(=O)(=O)c3ccccc3)CC2)cc1Cl
b: O=[N+]([O-])c1ncn(C23CC4CC(CC(C4)C2)C3)n1
Answer: a. COc1ccc(NC(=O)COC(=O)C2CCN(S(=O)(=O)c3ccccc3)CC2)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)COC(=O)C2CCN(S(=O)(=O)c3ccccc3)CC2)cc1Cl
COc1ccc(NC(=O)COC(=O)C2CCN(S(=O)(=O)c3ccccc3)CC2)cc1Cl
[2-(3-chloro-4-methoxyanilino)-2-oxoethyl]1-(benzenesulfonyl)piperidine-4-carboxylate